Xencor Inc. (NASDAQ: XNCR) is -26.35% lower on its value in year-to-date trading and has touched a low of $19.35 and a high of $43.61 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The XNCR stock was last observed hovering at around $29.74 in the last trading session, with the day’s loss setting it -0.19% off its average median price target of $49.00 for the next 12 months. It is also 49.05% off the consensus price target high of $58.00 offered by 13 analysts, but current levels are 1.5% higher than the price target low of $30.00 for the same period.
Currently trading at $29.55, the stock is 0.41% and 16.96% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.27 million and changing -0.64% at the moment leaves the stock -6.53% off its SMA200. XNCR registered -8.88% loss for a year compared to 6-month loss of -15.50%.
The stock witnessed a 24.89% gain in the last 1 month and extending the period to 3 months gives it a 9.77%, and is -4.03% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.52% over the week and 5.46% over the month.
Xencor Inc. (XNCR) has around 254 employees, a market worth around $1.75B and $326.60M in sales. Current P/E ratio is 16.77. Profit margin for the company is 33.30%. Distance from 52-week low is 52.67% and -32.24% from its 52-week high. The company has generated returns on investments over the last 12 months (5.90%).
Xencor Inc. (XNCR) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Xencor Inc. (XNCR) is a “Buy”. 13 analysts offering their recommendations for the stock have an average rating of 1.90, where 0 rate it as a Hold and 1 think it is a “Overweight”. 11 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.
Xencor Inc. is expected to release its quarterly report on 11/08/2022.The EPS is expected to grow by 212.70% this year.
Xencor Inc. (XNCR) Top Institutional Holders
The shares outstanding are 59.41M, and float is at 59.07M with Short Float at 5.00%.
Xencor Inc. (XNCR) Insider Activity
A total of 14 insider transactions have happened at Xencor Inc. (XNCR) in the last six months, with sales accounting for 9 and purchases happening 5 times. The most recent transaction is an insider sale by Desjarlais John R,the company’sSR. VICE PRESIDENT & CSO. SEC filings show that Desjarlais John R sold 1,172 shares of the company’s common stock on Mar 09 at a price of $29.13 per share for a total of $34140.0. Following the sale, the insider now owns 0.14 million shares.
Xencor Inc. disclosed in a document filed with the SEC on Mar 09 that Eckert Celia (VP, GENERAL COUNSEL) sold a total of 789 shares of the company’s common stock. The trade occurred on Mar 09 and was made at $28.91 per share for $22810.0. Following the transaction, the insider now directly holds 28976.0 shares of the XNCR stock.
Still, SEC filings show that on Mar 09, Kuch John J (SR. VICE PRESIDENT & CFO) disposed off 690 shares at an average price of $28.93 for $19965.0. The insider now directly holds 124,591 shares of Xencor Inc. (XNCR).
Xencor Inc. (XNCR): Who are the competitors?
The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 1.07% up over the past 12 months and AbbVie Inc. (ABBV) that is 26.29% higher over the same period. MacroGenics Inc. (MGNX) is -85.14% down on the 1-year trading charts.